BCG in management of superficial bladder cancer
- 31 December 1987
- Vol. 30 (6) , 515-519
- https://doi.org/10.1016/0090-4295(87)90428-6
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Histopathology of BCG and thiotepa treated bladdersUrological Research, 1986
- BCG in the management of superficial bladder cancerUrology, 1984
- Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1982
- Treatment of Residual, Non-infiltrating Bladder Cancer with Bacillus Calmette-guerinJournal of Urology, 1981
- The Effect of Mitomycin C on Superficial Bladder CancerJournal of Urology, 1981
- T1 Bladder TumoursBritish Journal of Urology, 1977
- Effect of dose, route, and schedule of BCG on antibody titer and survival of murine skin grafts across a weak histocompatibility barrierCancer, 1977
- CRITICAL REVIEW OF PREVIOUSLY REPORTED ANIMAL STUDIES OF TUMOR IMMUNOTHERAPY WITH NON‐SPECIFIC IMMUNOSTIMULANTSAnnals of the New York Academy of Sciences, 1976
- Benign Papilloma or Papillary Carcinoma of the Bladder?Journal of Urology, 1973
- Thiotepa Bladder Instillations: Therapy and Prophylaxis for Superficial Bladder TumorsJournal of Urology, 1969